In This Issue
Troglitazone withdrawn from market
Zonisamide approved for partial seizures
Cisapride to be taken off market, placed in controlled-access plan
July implementation set for hospital outpatient PPS
HMO patients have lower satisfaction but equal care, survey finds
FDA commissioner notes actions against Internet sites selling prescription drugs
Effects of DTC ads on care examined, policies suggested
Upcoming Meeting
Cost-effectiveness of pneumococcal conjugate vaccine analyzed
Glucosamine, chondroitin studies may overstate benefits in osteoarthritis, say authors
Supreme Court strikes down FDA tobacco regulation
Pneumococcal vaccine measure added for HEDIS 2001
Managed care undervalues beneficial nonprescription drugs
News Briefs
Effect of a highly restrictive formulary on the average prescription cost at a community health center
Ethics and managed care formularies
Fortresses and formularies: Drugs, ethics, and managed care
Fortresses and formularies: Response 1
Fortresses and formularies: Response 2
Fortresses and formularies: Response 3
Risperidone for control of agitation in dementia patients
Antimicrobial treatment patterns, resource utilization, and charges associated with acute sinusitis in asthma patients
Therapeutic interchange in community pharmacies in Virginia
Clinical trials in pharmacogenetics and pharmacogenomics: Methods and applications
Comparing medication use in two hemodialysis units against national dialysis databases
An intranet-based formulary management system
Career Opportunities